Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
Atthobari, Jarir, Asselbergs, Folkert W., Boersma, Cornelis, de Vries, Robin, Hillege, Hans L., van Gilst, Wiek H., Gansevoort, Ron T., de Jong, Paul E., de Jong-van den Berg, Lolkje T.W., Postma, Maarten J.
Published in Clinical therapeutics (01.03.2006)
Published in Clinical therapeutics (01.03.2006)
Get full text
Journal Article
The intensification of drug therapy for diabetes and its complications: evidence from 2 HMOs
Nau, David P, Garber, Mathew C, Herman, William H
Published in The American journal of managed care (01.02.2004)
Get full text
Published in The American journal of managed care (01.02.2004)
Journal Article
Predictors for high costs of hospital care in elderly hypertensive patients
Linjer, Erland, Jörnmark, Jan, Hedner, Thomas, Jönsson, Bengt, for the Stop Hypertension-2 Group
Published in Blood pressure (01.01.2006)
Published in Blood pressure (01.01.2006)
Get full text
Journal Article
More than just hype
Yusuf, Salim, Dagenais, Gilles
Published in Canadian Medical Association journal (CMAJ) (24.06.2003)
Get full text
Published in Canadian Medical Association journal (CMAJ) (24.06.2003)
Journal Article
An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54)
Gray, A., Clarke, P., Raikou, M., Adler, A., Stevens, R., Neil, A., Cull, C., Stratton, I., Holman, R.
Published in Diabetic medicine (01.06.2001)
Published in Diabetic medicine (01.06.2001)
Get full text
Journal Article